Trofinetide
ACP-2566-003
Phase 3 small_molecule completed
Quick answer
Trofinetide for Rett Syndrome is a Phase 3 program (small_molecule) at Acadia Pharmaceuticals B.V. with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Acadia Pharmaceuticals B.V.
- Indication
- Rett Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed